Home Study Details

    Program Type

    Home Study Webcast


    1.25 Contact Hour(s)

    Release Date

    Thursday, April 20, 2023

    Offline Date

    Saturday, April 20, 2024

    ACPE Expiration Date

    Monday, April 20, 2026

    Target Audience




    • Overview

      Every 7 minutes in our country, a person dies from prescription drug overdose, while a child is also born approximately every 30 minutes dependent (not addicted!) upon opioids. How do we as healthcare professionals offer non-stigmatic patient care and contribute to the progress of society in the right direction? Addiction, classified as substance-use disorder, is likened to an iceberg or a weed, in that the issues underneath the surface are typically even more complicated than what is viewed from above. Thus, in this continuing education discussion, we will review the core concepts and understandings of opioid-use disorder, commonly referred to as opioid addiction. We will then discuss the medication-assisted treatments of methadone and buprenorphine, including key clinical pearls that will immediately improve one’s patient care. Both methadone and buprenorphine are continually improving and savings lives, yet each comes with its own baggage that we, as healthcare professionals, need to stay abreast on. This discussion is part of the overall Substances of Abuse Specialty Pharmacist (SASP) certificate training program. So join us for a conversation on addiction that will be sure to impact your patient care, maybe your own opinions, and, perhaps, even your holiday family meal conversations!


      • Slide Document :   23054H99_2pp.pdf
      • Slide Document :   23054H99_6pp.pdf

      Financial Support By

    • Pharmacist

      Identify proper treatment selections, dosages, and key patient counseling points for the most common medication assisted therapies of methadone and buprenorphine
      Recognize terminology that contributes to the stigma of addiction
      Describe the pathophysiology behind substance use disorder, commonly referred to as addiction
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-23-054-H99-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).